Ad is loading...
EQIAX
Price
$12.00
Change
-$0.04 (-0.33%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

EQIAX vs RNWFX

Header iconEQIAX vs RNWFX Comparison
Open Charts EQIAX vs RNWFXBanner chart's image
Allspring Emerging Markets Eq Inc A
Price$12.00
Change-$0.04 (-0.33%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
EQIAX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQIAX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQIAX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. EQIAX (359M). EQIAX pays higher dividends than RNWFX: EQIAX (1.85) vs RNWFX (1.51). EQIAX was incepted earlier than RNWFX: EQIAX (12 years) vs RNWFX (23 years). EQIAX is a more actively managed with annual turnover of: 68.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than EQIAX: RNWFX (250) vs EQIAX (1000). EQIAX annual gain was more profitable for investors over the last year : 17.78 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. EQIAX (13.77).
EQIAXRNWFXEQIAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD11.0877.099156%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets359M60.9B1%
Annual Yield % from dividends1.851.51123%
Returns for 1 year17.7811.54154%
Returns for 3 years-2.48-14.5517%
Returns for 5 years13.7717.1780%
Returns for 10 years22.0441.0054%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics